URL has been copied successfully!
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- BTIG analyst Julian Harrison downgraded Outlook Therapeutics Inc (NASDAQ:OTLK) from Buy to Neutral. Outlook Therapeutics shares closed at $0.23 on Friday. See how other analysts view this stock.
- Morgan Stanley analyst Shane Brett downgraded Applied Materials Inc (NASDAQ:AMAT) from Overweight to Equal-Weight and announced a $502 price target. Applied Materials shares closed at $436.62 on Friday. See how …
Please follow us:
This post was originally published here
